Global Recombinant Proteins Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- SKU ID : GIR-GIR1809270001 13194396
- |
- Publishing Date: 21-Nov-2018
- |
- Region: Global
- |
- No. of pages: 115
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Scope of the Report:
Increasing research and development expenditure on biologic drugs is expected to boost demand for recombinant proteins for research purposes
The global Recombinant Proteins market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Recombinant Proteins.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Recombinant Proteins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Recombinant Proteins market by product type and applications/end industries.
Market Segment by Companies, this report covers
Crown Bioscience, Inc
ProSpec Tany TechnoGene, Ltd.
BPS Bioscience, Inc.
Sigma Aldrich Company Ltd.
Novoprotein Scientific
PeproTech, Inc.
Feldan Bio, Inc.
BioVision, Inc.
HumanZyme, Inc.
GenScript Biotech Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Market Segment by Applications, can be divided into
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Others
Scope of the Report:
Increasing research and development expenditure on biologic drugs is expected to boost demand for recombinant proteins for research purposes
The global Recombinant Proteins market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Recombinant Proteins.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Recombinant Proteins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Recombinant Proteins market by product type and applications/end industries.
Market Segment by Companies, this report covers
Crown Bioscience, Inc
ProSpec Tany TechnoGene, Ltd.
BPS Bioscience, Inc.
Sigma Aldrich Company Ltd.
Novoprotein Scientific
PeproTech, Inc.
Feldan Bio, Inc.
BioVision, Inc.
HumanZyme, Inc.
GenScript Biotech Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Market Segment by Applications, can be divided into
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
